MENLO PARK, Calif.--(BUSINESS WIRE)--SRI International, an independent nonprofit research and development organization, announced today the continued progress of several compounds that show promise as therapeutics against cancer. SRI executives will be on hand at the 2007 meeting of the American Society of Clinical Oncology (ASCO) to discuss potential partnerships for further development of these anticancer agents.
